STAT stories you may have missed 

The high cost of multiple sclerosis treatments has forced 40% of patients to alter their use of the medicines, cutting back or skipping doses altogether.

A 'radical proposition': Alexis Borisy, a health care veteran, believes he can invent and develop new drugs, and bring prices down.

Apple's CEO predicted last year that its biggest impact on humankind would be in health. But Apple did not discuss any health-specific products at a massive technology trade show last week. 

Not so fast: 5 reasons to view declining cancer death rates with a dash of skepticism.

California plans to sell its own generic drugs in hopes of lowering costs.

Unsealed emails make clear that when some prescribers raised fears of OxyContin misuse, Purdue's sales force consistently responded with misleading assertions.

“We need the president speaking up more,” said Sen. Chuck Grassley, pleading for the White House to be more aggressive in pushing Congress to pass drug pricing legislation.